Mitsuyoshi Yoshimoto

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Hirofumi Fujii · 3 shared papers, 2012–2024 · strength 0.52
   • Paper αvβ3 integrin-targeted magnetic resonance imaging in a pancreatic cancer mouse model using RGD-modified liposomes encap… DOI 10.1371/journal.pone.0310984↗
   • Paper Long-Term Therapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2/M Arrest in Pancreatic Du… DOI 10.3390/pharmaceutics17010009↗
   • Paper In vivo SPECT imaging with 111In-DOTA-c(RGDfK) to detect early pancreatic cancer in a hamster pancreatic carcinogenesis… DOI 10.2967/jnumed.111.099630↗
2. Yukie Yoshii · 4 shared papers, 2019–2022 · strength 0.42
   • Paper In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-In… DOI 10.3390/ijms23105807↗
   • Paper Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xeno… DOI 10.1097/mnm.0000000000001442↗
   • Paper 64Cu-Intraperitoneal Radioimmunotherapy: A Novel Approach for Adjuvant Treatment in a Clinically Relevant Preclinical M… DOI 10.2967/jnumed.118.225045↗
3. Aya Sugyo · 4 shared papers, 2019–2022 · strength 0.42
   • Paper In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-In… DOI 10.3390/ijms23105807↗
   • Paper Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xeno… DOI 10.1097/mnm.0000000000001442↗
   • Paper 64Cu-Intraperitoneal Radioimmunotherapy: A Novel Approach for Adjuvant Treatment in a Clinically Relevant Preclinical M… DOI 10.2967/jnumed.118.225045↗
4. Hiroki Matsumoto · 4 shared papers, 2019–2022 · strength 0.42
   • Paper In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-In… DOI 10.3390/ijms23105807↗
   • Paper Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xeno… DOI 10.1097/mnm.0000000000001442↗
   • Paper 64Cu-Intraperitoneal Radioimmunotherapy: A Novel Approach for Adjuvant Treatment in a Clinically Relevant Preclinical M… DOI 10.2967/jnumed.118.225045↗
5. Tatsuya Higashi · 4 shared papers, 2019–2022 · strength 0.42
   • Paper In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-In… DOI 10.3390/ijms23105807↗
   • Paper Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xeno… DOI 10.1097/mnm.0000000000001442↗
   • Paper 64Cu-Intraperitoneal Radioimmunotherapy: A Novel Approach for Adjuvant Treatment in a Clinically Relevant Preclinical M… DOI 10.2967/jnumed.118.225045↗
6. Fukiko Hihara · 3 shared papers, 2020–2022 · strength 0.32
   • Paper In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-In… DOI 10.3390/ijms23105807↗
   • Paper Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xeno… DOI 10.1097/mnm.0000000000001442↗
   • Paper Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancer. DOI 10.1038/s41598-020-61056-5↗
7. Chika Igarashi · 3 shared papers, 2020–2022 · strength 0.32
   • Paper In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-In… DOI 10.3390/ijms23105807↗
   • Paper Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xeno… DOI 10.1097/mnm.0000000000001442↗
   • Paper Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancer. DOI 10.1038/s41598-020-61056-5↗
8. Motohiro Kojima · 1 shared paper, 2024 · strength 0.21
   • Paper Long-Term Therapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2/M Arrest in Pancreatic Du… DOI 10.3390/pharmaceutics17010009↗
9. Makoto Ueno · 1 shared paper, 2022 · strength 0.13
   • Paper In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-In… DOI 10.3390/ijms23105807↗
10. Michihiro Mutoh · 1 shared paper, 2012 · strength 0.03
    • Paper In vivo SPECT imaging with 111In-DOTA-c(RGDfK) to detect early pancreatic cancer in a hamster pancreatic carcinogenesis… DOI 10.2967/jnumed.111.099630↗
11. Keiji Wakabayashi · 1 shared paper, 2012 · strength 0.03
    • Paper In vivo SPECT imaging with 111In-DOTA-c(RGDfK) to detect early pancreatic cancer in a hamster pancreatic carcinogenesis… DOI 10.2967/jnumed.111.099630↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.